Format

Send to

Choose Destination
See comment in PubMed Commons below
Adv Exp Med Biol. 2005;569:109-13.

Effect of N-3 polyunsaturated fatty acid supplementation in pregnancy: the Nuheal trial.

Author information

1
Department of Paediatrics, University of Pécs, Pécs, Hungary.

Abstract

In this placebo controlled, randomised, double blind trial, pregnant women received from the 20th week of gestation onwards either 500 mg docosahexaenoic acid (DHA), 400 mg 5-methyl-tetra-hydro-folate (5-MTHF), or placebo, or a combination of 500 mg DHA and 400 mg 5-MTHF. The dietary supplements were well tolerated; the dropout rates did not differ significantly in the active arms of the study (10% to 19%) from that seen in the placebo group (13%). DHA supplementation resulted in significant enhancement of the contribution of DHA to maternal, placental and venous cord blood lipids.

PMID:
16137113
DOI:
10.1007/1-4020-3535-7_15
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center